BRD2 and ovarian carcinoma: During this time, follicle stimulating hormone (FSH) levels remain elevated, whereas anti-Mullerian hormone (AMH) and inhibin B levels, as well as estrogen levels, decrease (42, 43), and sex hormone levels are associated with breast, uterine and ovarian cancers (44).